Avita Medical | 1811094D - 流动资产



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 150.11M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


流动资产 更改 日
Accuray USD 292.39M 11.22M 2025-12
Celltrion KRW 470.6B 5.07T 2025-12
Clinuvel Pharmaceuticals AUD 261.38M 1.59M 2025-12
Cochlear AUD 1.37B 43.9M 2025-12
CSL USD 11.85B 1000K 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Mayne Pharma AUD 460.59M 14.71M 2024-06
Medical Developments International AUD 33.75M 1.79M 2025-12
Nanosonics AUD 234.13M 8.81M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pacific Edge NZD 13.77M 15.81M 2026-06
Paradigm Biopharmaceuticals AUD 21.67M 2.46M 2025-12
Pharma Mar EUR 273.45M 9.96M 2026-03
Polynovo AUD 69.23M 7.87M 2025-12
PYC Therapeutics AUD 153.74M 23.79M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Ramsay Health Care AUD 3.56B 480.3M 2025-12
ResMed USD 3.82B 193.06M 2025-12
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03